12 results

• Keytruda, Similar Cancer Drugs May Increase Risk of Pulmonary Embolism: Study

  October 17, 2024

  Martha Garcia

  New research indicates the use of certain cancer treatment drugs, like Keytruda and Opdivo, could pose a high risk of life-threatening cardiovascular events, adding to recent concerns about the class of medications.

• FDA Advisors Vote for Restrictions on Opdivo, Keytruda, Similar Stomach Cancer Drugs

  September 30, 2024

  Irvin Jackson

  Independent scientific advisory board is calling for restrictions on stomach cancer drugs like Keytruda and Opdivo, saying they do little to extend the lives of certain cancer patients.

• FDA Advisors Set to Consider Stomach Cancer Restrictions for Yervoy, Opdivo, Keytruda

  August 23, 2024

  Irvin Jackson

  An FDA advisory committee has been asked to determine if there should be restrictions on the use of some popular cancer drugs, like Opdivo and Keytruda, for the treatment of stomach cancer, following years of concerns about the drugs' safety risks.

• Opdivo Could Extend Life of Mesothelioma Victims: Study

  February 3, 2021

  Martha Garcia

  Opdivo may help extend the life of mesothelioma patients, according to the findings of a new study.

• FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma

  October 5, 2020

  Irvin Jackson

  The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.

• Only One-Fifth Of Cancer Drugs Approved Through Accelerated FDA Program Actually Work: Study

  May 31, 2019

  Martha Garcia

  Most cancer drugs fast-tracked through a special FDA program do not appear to actually help cancer patients live longer, according to the findings of a new study.

• Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths

  September 8, 2017

  Russell Maas

  After halting clinical trials involving the cancer drug Keytruda for treatment of multiple myeloma, the FDA has expanded the suspension to trials involving Opdivo, a similar medication.

• Opdivo/Yervoy Drug Combo Toxic For Most Cancer Patients: Study

  August 24, 2017

  Irvin Jackson

  A new study warns that combination cancer therapy involving Opdivo and Yervoy may often be too toxic for patients, resulting in hospitalizations and emergency room visits due to immune system adverse events.

• Opdivo, Yervoy Treatments May Slow Mesothelioma Progression: Study

  June 14, 2017

  Irvin Jackson

  The cancer drugs Opdivo and Yervoy may slow the progression of mesothelioma, according to the findings of a new study.

• Some Drug Companies, Hospitals Oversell Cancer Treatment Benefits: CNN Report

  April 27, 2017

  Martha Garcia

  An investigative report finds that cancer drugs and treatments are often oversold, exaggerating their effectiveness.